Tianjin International Joint Academy of Biotechnology & Medicine
- Europe, Asia, …
- China, Ukraine
- Human Medicines, Biopharmaceuticals, …
- Service category
- Academic collaboration, Contract manufacturing, filling and packaging, …
Your company? Get access to this profile.
China needs to position itself as a global top player in biomedical innovation and industrialization , to boost the biomedical sector and to promote the development and opening-up of the Tianjin Binhai New Area. Four Ministries and One Municipal Government, namely, the Ministry of Science and Technology, the Ministry of Commerce, the Ministry of Health, the State Food and Drug Administration, and Tianjin Municipality, shed light on the Binhai New Area for being and established BioMed Zone. At the heart of the zone is the iconic 340-plus-mu TJAB, located at No. 220 Dongting Road, TEDA. Blessed with an investment a generous 1.1 billion Yuan, this institute dreams big, with a construction area of 350,000 square meters on its blueprints. This first project at TJAB, the 70,000-square-meter building, has been ready to serve since June 2009. Equipped with an abundant and diverse array of state-of-the-art devices in each of the eleven technical platforms for R&D of new pharmaceuticals, TJAB is proud to cater to R&D teams. Up till now, TJAB has been home to more than 104 R&D teams.
Pictures of this company
You might also be interested in
Sourcing this company's services?Send inquiry anonymously »